Deep Track Capital, LP

Holdings History for Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Symbol: NRIX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 5,500,000 shares
Security Ownership %: 7.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Deep Track Capital, LP ownership in Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX)

15 May 2025 - Deep Track Capital, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,500,000 shares of Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX). This represents 7.2% ownership of the company. In their previous filing dated 14 Feb 2025, Deep Track Capital, LP had reported owning 4,125,000 shares, indicating an increase of +33%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Deep Track Capital, LP	7.2%	+35%	$63,580,000	5,500,000	+1,375,000	+33%	$11.56	13G/A	31 Mar 2025	15 May 2025, 08:44
Deep Track Capital, LP	5.4%	+30%	$47,685,000	4,125,000	+1,125,000	+38%	$11.56	13G	07 Feb 2025	14 Feb 2025, 16:31
Deep Track Capital, LP	4.2%		$34,680,000	3,000,000			$11.56	13G/A	31 Dec 2024	14 Feb 2025, 08:42

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	1.6%	-0%	$55,966,902	6,057,024	-7,886	-0.13%	$9.24	Q3 2025
30 Jun 2025	2.2%	+0.21%	$69,079,325	6,064,910	+564,910	+10%	$11.39	Q2 2025
31 Mar 2025	2.1%	+0.96%	$65,340,000	5,500,000	+2,500,000		$11.88	Q1 2025
31 Dec 2024	2.1%	-0.61%	$56,520,000	3,000,000	-868,104	-22%	$18.84	Q4 2024
30 Sep 2024	2.8%	-0.09%	$86,916,297	3,868,104	-123,396	-3.1%	$22.47	Q3 2024
30 Jun 2024	2.5%	+0.6%	$83,302,605	3,991,500	+993,670	+33%	$20.87	Q2 2024
31 Mar 2024	1.3%	0%	$44,068,101	2,997,830	0		$14.70	Q1 2024
31 Dec 2023	1.1%	0%	$30,937,606	2,997,830	0		$10.32	Q4 2023
30 Sep 2023	0.91%	0%	$23,562,944	2,997,830	0		$7.86	Q3 2023
30 Jun 2023	1.4%	0%	$29,948,322	2,997,830	0		$9.99	Q2 2023
31 Mar 2023	1.1%	+0.28%	$26,620,730	2,997,830	+731,261	+32%	$8.88	Q1 2023
31 Dec 2022	1.1%	+0.1%	$24,886,928	2,266,569	+212,948	+10%	$10.98	Q4 2022
30 Sep 2022	1.3%	-0.25%	$26,759,000	2,053,621	-382,543	-16%	$13.03	Q3 2022
30 Jun 2022	2.2%	+2.2%	$30,866,000	2,436,164	+2,436,164	NEW	$12.67	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.